|View printer-friendly version|
|June 06, 2011 5:28 p.m.|
|Teva to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference|
|Jerusalem, Israel, June 6, 2011 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Goldman Sachs 32nd Annual Global Healthcare Conference with William Marth, President & CEO, Teva Pharmaceuticals - Americas, presenting on Tuesday, June 7, 2011. |
What: Teva Presentation at the Goldman Sachs 32nd Annual Global Healthcare Conference
Who: William Marth, President & CEO, Teva Pharmaceuticals - Americas
When: Tuesday, June 7, 2011, at 2:50 PM PT
Where: www.tevapharm.com/financial/ or
How: Live over the Internet - log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,450 molecules and a direct presence in 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone®, is the number one prescribed treatment for multiple sclerosis. Teva employs approximately 40,000 people around the world and reached $16.1 billion in net sales in 2010.